Breaking barriers: The potential of nanosystems in antituberculosis therapy
Article in Bioactive Materials (May 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Nanomedicine and Its Applications in Combating Resistance Relating to Opportunistic Pathogens With Special Reference to Tuberculosis
Book chapter (January 2021)
In Vitro, In Vivo and In Silico Effectiveness of LASSBio-1386, an N-Acyl Hydrazone Derivative Phosphodiesterase-4 Inhibitor, Against Leishmania amazonensis
Article in Frontiers in Pharmacology (December 2020)